45 / 182
SALES
SUBJECT
TO SEP
SEP
3
%
97
%
TOP 10 BRANDS
TURNOVER
R604
MILLION
TRADING
PROFIT
R90
MILLION
(2015: R79m)
Non-SEP
OVERVIEW
The division provides products into the independents and pharmaceutical wholesale,
corporate pharmacy and retail channels. It has leading brands in the following
categories:
Analgesics
Energy
Feminine
Hygiene
Digestive
well being
•
Market growth driven by growing middle
class and the global trend towards self-care
as consumers are becoming more educated
•
Growth driven by new product formats and
a focus on the prevention and treatment of
lifestyle diseases
•
Consumer expectations for improved
healthcare are increasing with access to
digital information making them far more
knowledgeable about their health
•
Current pressures on the consumer are
forcing trading down to smaller pack sizes or
cheaper alternatives making pack and price
offerings more important
•
More regulated environment resulting in
increased compliance costs
MARKET TRENDS
TOP TEN BRANDS
Panado
•
Bioplus
•
Probiflora
•
Compral
•
Cepacol
•
GynaGuard
•
ViralGuard
•
Gummy Vites
•
Codral
•
ArthroGuard
STRATEGIC FOCUS
•
Continued investment in marketing to
protect and build the core brands
•
Expand non-regulated product portfolio
via innovation and acquisition
•
Stock and demand management
•
Regulatory compliance, specifically CAMs
Analgesics
This category showed growth of 8.8% in value and
4.9% in volume. Both Panado and Compral grow
ahead of the category in value and volume.
Cough, colds, flu and congestion
LCC continued to show strong growth (12.6%),
well ahead of the market
Energy supplements
Bioplus continues to lead the single sachet/
application market in FMCG
Bioplus is growing at 15%, ahead of the market, in
FMCG and show good growth in its market share
Gut Health
Probiflora retains the market leader spot in this
segment of the market in FMCG.
PERFORMANCE
Vitamins,
Minerals and
Supplements
Cough,
colds, flu and
congestion
FIVE
SIX
THREE
ONE
FOUR
TWO
OUR PERFORMANCE
(continued)
| 41
Integrated Report 2016